bromopyruvate has been researched along with Skin Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasunuma, N; Kagaya, M; Manabe, M; Noguchi, N; Osada, SI; Ueki, S; Yamada, M | 1 |
| Nickoloff, BJ; Qin, JZ; Xin, H | 1 |
2 other study(ies) available for bromopyruvate and Skin Neoplasms
| Article | Year |
|---|---|
Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model.
Topics: Administration, Cutaneous; Animals; Apoptosis; Cell Line, Tumor; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Melanoma, Experimental; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Pyruvates; Reactive Oxygen Species; Skin; Skin Neoplasms; Spheroids, Cellular; Treatment Outcome | 2018 |
3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines.
Topics: Acetylcysteine; Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Glutathione; Humans; Melanoma; Membrane Potential, Mitochondrial; Necrosis; Pyruvates; Skin Neoplasms; Superoxides | 2010 |